BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu G, Wang J, Park YJ, Tsuruta Y, Lorne EF, Zhao X, Abraham E. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol 2008;181:4240-6. [PMID: 18768881 DOI: 10.4049/jimmunol.181.6.4240] [Cited by in Crossref: 117] [Cited by in F6Publishing: 122] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Kang G, Lee H, Kang YP, Kim EJ, Kim HJ, Byun HJ, Park MK, Cho H, Kwon SW, Lee C. High-mobility group box 1 suppresses resolvin D1-induced phagocytosis via induction of resolvin D1-inactivating enzyme, 15-hydroxyprostaglandin dehydrogenase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015;1852:1981-8. [DOI: 10.1016/j.bbadis.2015.07.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chirico V, Lacquaniti A, Leonardi S, Grasso L, Rotolo N, Romano C, Di Dio G, Lionetti E, David A, Arrigo T, Salpietro C, La Rosa M. Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. Clin Microbiol Infect 2015;21:368.e1-9. [PMID: 25658530 DOI: 10.1016/j.cmi.2014.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
3 Liu G, Yang Y, Yang S, Banerjee S, De Freitas A, Friggeri A, Davis KI, Abraham E. The receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils. PLoS One 2011;6:e25843. [PMID: 21998707 DOI: 10.1371/journal.pone.0025843] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
4 Grégoire M, Uhel F, Lesouhaitier M, Gacouin A, Guirriec M, Mourcin F, Dumontet E, Chalin A, Samson M, Berthelot L, Tissot A, Kerjouan M, Jouneau S, Le Tulzo Y, Tarte K, Zmijewski JW, Tadié J. Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS. Eur Respir J 2018;52:1702590. [DOI: 10.1183/13993003.02590-2017] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 12.8] [Reference Citation Analysis]
5 Vernon PJ, Tang D. Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling. Antioxid Redox Signal 2013;18:677-91. [PMID: 22871044 DOI: 10.1089/ars.2012.4810] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 10.5] [Reference Citation Analysis]
6 Lim PN, Cervantes MM, Pham LK, Rothchild AC. Alveolar macrophages: novel therapeutic targets for respiratory diseases. Expert Rev Mol Med 2021;23:e18. [PMID: 34823627 DOI: 10.1017/erm.2021.21] [Reference Citation Analysis]
7 Pietropaoli A, Georas SN. Resolving lung injury: a new role for Tregs in controlling the innate immune response. J Clin Invest 2009;119:2891-4. [PMID: 19770510 DOI: 10.1172/JCI40880] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
8 Lu B, Wang C, Wang M, Li W, Chen F, Tracey KJ, Wang H. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol 2014;10:713-27. [PMID: 24746113 DOI: 10.1586/1744666X.2014.909730] [Cited by in Crossref: 82] [Cited by in F6Publishing: 53] [Article Influence: 10.3] [Reference Citation Analysis]
9 Friggeri A, Banerjee S, Biswas S, de Freitas A, Liu G, Bierhaus A, Abraham E. Participation of the receptor for advanced glycation end products in efferocytosis. J Immunol 2011;186:6191-8. [PMID: 21502377 DOI: 10.4049/jimmunol.1004134] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
10 Unterwalder N, Meisel C, Savvatis K, Hammoud B, Fotopoulou C, Volk HD, Reinke P, Schefold JC. High-mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression. Mediators Inflamm 2010;2010:745724. [PMID: 20652004 DOI: 10.1155/2010/745724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Gaggar A, Rowe SM, Matthew H, Blalock JE. Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation. Open Respir Med J 2010;4:32-8. [PMID: 20448817 DOI: 10.2174/1874306401004020032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
12 Clarke MC, Talib S, Figg NL, Bennett MR. Vascular Smooth Muscle Cell Apoptosis Induces Interleukin-1–Directed Inflammation: Effects of Hyperlipidemia-Mediated Inhibition of Phagocytosis. Circulation Research 2010;106:363-72. [DOI: 10.1161/circresaha.109.208389] [Cited by in Crossref: 126] [Cited by in F6Publishing: 62] [Article Influence: 10.5] [Reference Citation Analysis]
13 Bevers EM, Williamson PL. Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane. Physiol Rev. 2016;96:605-645. [PMID: 26936867 DOI: 10.1152/physrev.00020.2015] [Cited by in Crossref: 179] [Cited by in F6Publishing: 163] [Article Influence: 29.8] [Reference Citation Analysis]
14 Zhu S, Li W, Ward MF, Sama AE, Wang H. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets 2010;9:60-72. [PMID: 19906009 DOI: 10.2174/187152810791292872] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
15 Chen H, Bai C, Wang X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 2010;4:773-783. [PMID: 21128752 DOI: 10.1586/ers.10.71] [Cited by in Crossref: 151] [Cited by in F6Publishing: 148] [Article Influence: 13.7] [Reference Citation Analysis]
16 Kang R, Tang D. What Is the Pathobiology of Inflammation to Cell Death? Apoptosis, Necrosis, Necroptosis, Autophagic Cell Death, Pyroptosis, and NETosis. In: Maiuri MC, De Stefano D, editors. Autophagy Networks in Inflammation. Cham: Springer International Publishing; 2016. pp. 81-106. [DOI: 10.1007/978-3-319-30079-5_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Greenlee-Wacker MC. Clearance of apoptotic neutrophils and resolution of inflammation. Immunol Rev 2016;273:357-70. [PMID: 27558346 DOI: 10.1111/imr.12453] [Cited by in Crossref: 152] [Cited by in F6Publishing: 141] [Article Influence: 30.4] [Reference Citation Analysis]
18 Xia CQ, Campbell KA, Clare-Salzler MJ. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Curr Opin Organ Transplant 2009;14:338-43. [PMID: 19444106 DOI: 10.1097/MOT.0b013e32832ce943] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
19 Patel VS, Sitapara RA, Gore A, Phan B, Sharma L, Sampat V, Li JH, Yang H, Chavan SS, Wang H, Tracey KJ, Mantell LL. High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice. Am J Respir Cell Mol Biol 2013;48:280-7. [PMID: 23087050 DOI: 10.1165/rcmb.2012-0279OC] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
20 Kanakoudi-Tsakalidou F, Farmaki E, Tzimouli V, Taparkou A, Paterakis G, Trachana M, Pratsidou-Gertsi P, Nalbanti P, Papachristou F. Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options? Lupus 2014;23:305-12. [PMID: 24399813 DOI: 10.1177/0961203313519157] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
21 Wang X, Bu HF, Zhong W, Asai A, Zhou Z, Tan XD. MFG-E8 and HMGB1 are involved in the mechanism underlying alcohol-induced impairment of macrophage efferocytosis. Mol Med. 2013;19:170-182. [PMID: 23552724 DOI: 10.2119/molmed.2012.00260] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
22 Tajbakhsh A, Gheibihayat SM, Mortazavi D, Medhati P, Rostami B, Savardashtaki A, Momtazi-Borojeni AA. The Effect of Cigarette Smoke Exposure on Efferocytosis in Chronic Obstructive Pulmonary Disease; Molecular Mechanisms and Treatment Opportunities. COPD 2021;:1-14. [PMID: 34865568 DOI: 10.1080/15412555.2021.1978419] [Reference Citation Analysis]
23 Chen K, Murao A, Arif A, Takizawa S, Jin H, Jiang J, Aziz M, Wang P. Inhibition of Efferocytosis by Extracellular CIRP-Induced Neutrophil Extracellular Traps. J Immunol 2021;206:797-806. [PMID: 33380498 DOI: 10.4049/jimmunol.2000091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Takamiya R, Hung CC, Hall SR, Fukunaga K, Nagaishi T, Maeno T, Owen C, Macias AA, Fredenburgh LE, Ishizaka A, Blumberg RS, Baron RM, Perrella MA. High-mobility group box 1 contributes to lethality of endotoxemia in heme oxygenase-1-deficient mice. Am J Respir Cell Mol Biol 2009;41:129-35. [PMID: 19097991 DOI: 10.1165/rcmb.2008-0331OC] [Cited by in Crossref: 58] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
25 He M, Kubo H, Morimoto K, Fujino N, Suzuki T, Takahasi T, Yamada M, Yamaya M, Maekawa T, Yamamoto Y, Yamamoto H. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep 2011;12:358-64. [PMID: 21399623 DOI: 10.1038/embor.2011.28] [Cited by in Crossref: 133] [Cited by in F6Publishing: 129] [Article Influence: 12.1] [Reference Citation Analysis]
26 Bennett M, Yu H, Clarke M. Signalling from dead cells drives inflammation and vessel remodelling. Vascul Pharmacol 2012;56:187-92. [PMID: 22306421 DOI: 10.1016/j.vph.2012.01.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
27 Sharma L, Wu J, Patel V, Sitapara R, Rao NV, Kennedy TP, Mantell LL. Partially-desulfated heparin improves survival in Pseudomonas pneumonia by enhancing bacterial clearance and ameliorating lung injury. J Immunotoxicol 2014;11:260-7. [PMID: 24099632 DOI: 10.3109/1547691X.2013.839587] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
28 Nabeyama A, Kurita A, Asano K, Miyake Y, Yasuda T, Miura I, Nishitai G, Arakawa S, Shimizu S, Wakana S, Yoshida H, Tanaka M. xCT deficiency accelerates chemically induced tumorigenesis. Proc Natl Acad Sci U S A 2010;107:6436-41. [PMID: 20308543 DOI: 10.1073/pnas.0912827107] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
29 Chen Y, Sun W, Gao R, Su Y, Umehara H, Dong L, Gong F. The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis. Rheumatology (Oxford). 2013;52:1739-1747. [PMID: 23584368 DOI: 10.1093/rheumatology/ket134] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
30 Schaper F, de Leeuw K, Horst G, Bootsma H, Limburg PC, Heeringa P, Bijl M, Westra J. High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells. Rheumatology (Oxford) 2016;55:2260-70. [PMID: 27632996 DOI: 10.1093/rheumatology/kew324] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
31 Lu H, Zhang Z, Barnie PA, Su Z. Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury. Cytokine & Growth Factor Reviews 2019;47:74-82. [DOI: 10.1016/j.cytogfr.2019.05.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
32 Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius Å, Sundberg E, Harris HE. HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration. J Rheumatol 2013;40:1604-13. [PMID: 23858044 DOI: 10.3899/jrheum.120987] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
33 Sitapara RA, Gauthier AG, Valdés-Ferrer SI, Lin M, Patel V, Wang M, Martino AT, Perron JC, Ashby CR Jr, Tracey KJ, Pavlov VA, Mantell LL. The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation. Mol Med 2020;26:63. [PMID: 32600307 DOI: 10.1186/s10020-020-00177-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
34 Fang P, Liang J, Jiang X, Fang X, Wu M, Wei X, Yang W, Hou W, Zhang Q. Quercetin Attenuates d-GaLN-Induced L02 Cell Damage by Suppressing Oxidative Stress and Mitochondrial Apoptosis via Inhibition of HMGB1. Front Pharmacol 2020;11:608. [PMID: 32431618 DOI: 10.3389/fphar.2020.00608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Miao J, Ye S, Lan J, Ye P, Wen Q, Mei L, Liu X, Lin J, Zhou X, Du S, Liu X, Li H. Nuclear HMGB1 promotes the phagocytic ability of macrophages. Exp Cell Res 2020;393:112037. [PMID: 32360192 DOI: 10.1016/j.yexcr.2020.112037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 García-Arnandis I, Guillén MI, Gomar F, Pelletier JP, Martel-Pelletier J, Alcaraz MJ. High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther 2010;12:R165. [PMID: 20799933 DOI: 10.1186/ar3124] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 5.7] [Reference Citation Analysis]
37 Sharma L, Wu W, Dholakiya SL, Gorasiya S, Wu J, Sitapara R, Patel V, Wang M, Zur M, Reddy S, Siegelaub N, Bamba K, Barile FA, Mantell LL. Assessment of phagocytic activity of cultured macrophages using fluorescence microscopy and flow cytometry. Methods Mol Biol 2014;1172:137-45. [PMID: 24908301 DOI: 10.1007/978-1-4939-0928-5_12] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
38 Patel V, Dial K, Wu J, Gauthier AG, Wu W, Lin M, Espey MG, Thomas DD, Ashby CR Jr, Mantell LL. Dietary Antioxidants Significantly Attenuate Hyperoxia-Induced Acute Inflammatory Lung Injury by Enhancing Macrophage Function via Reducing the Accumulation of Airway HMGB1. Int J Mol Sci 2020;21:E977. [PMID: 32024151 DOI: 10.3390/ijms21030977] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
39 Wang H, Zhu S, Zhou R, Li W, Sama AE. Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med 2008;10:e32. [PMID: 18980707 DOI: 10.1017/S1462399408000884] [Cited by in Crossref: 75] [Cited by in F6Publishing: 55] [Article Influence: 5.4] [Reference Citation Analysis]
40 Seitz HM, Matsushima GK. Dendritic cells in systemic lupus erythematosus. Int Rev Immunol 2010;29:184-209. [PMID: 20367140 DOI: 10.3109/08830181003602507] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
41 Kim WJ, Park HJ, Choi YJ, Kwon EY, Kim BM, Lee JH, Chang JH, Lee Kang J, Choi JH. Association between Genetic Variations of MERTK and Chronic Obstructive Pulmonary Disease in Koreans. J Korean Med Sci 2018;33:e56. [PMID: 29359540 DOI: 10.3346/jkms.2018.33.e56] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Na M, Mohammad M, Fei Y, Wang W, Holdfeldt A, Forsman H, Ali A, Pullerits R, Jin T. Lack of Receptor for Advanced Glycation End Products Leads to Less Severe Staphylococcal Skin Infection but More Skin Abscesses and Prolonged Wound Healing. J Infect Dis 2018;218:791-800. [PMID: 29329449 DOI: 10.1093/infdis/jiy007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
43 Rojas A, Delgado-López F, González I, Pérez-Castro R, Romero J, Rojas I. The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor. Cell Signal 2013;25:609-14. [PMID: 23200851 DOI: 10.1016/j.cellsig.2012.11.022] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 6.0] [Reference Citation Analysis]
44 Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012;18:509-519. [PMID: 22481418 DOI: 10.1038/nm.2715] [Cited by in Crossref: 311] [Cited by in F6Publishing: 298] [Article Influence: 31.1] [Reference Citation Analysis]
45 Wang M, Gauthier AG, Kennedy TP, Wang H, Velagapudi UK, Talele TT, Lin M, Wu J, Daley L, Yang X, Patel V, Mun SS, Ashby CR Jr, Mantell LL. 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function. Mol Med 2021;27:79. [PMID: 34271850 DOI: 10.1186/s10020-021-00334-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Wagener BM, Hu PJ, Oh JY, Evans CA, Richter JR, Honavar J, Brandon AP, Creighton J, Stephens SW, Morgan C, Dull RO, Marques MB, Kerby JD, Pittet JF, Patel RP. Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: A preclinical experimental study. PLoS Med 2018;15:e1002522. [PMID: 29522519 DOI: 10.1371/journal.pmed.1002522] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
47 Zhu S, Ashok M, Li J, Li W, Yang H, Wang P, Tracey KJ, Sama AE, Wang H. Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med 2009;15:275-82. [PMID: 19593412 DOI: 10.2119/molmed.2009.00062] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 4.6] [Reference Citation Analysis]
48 Rothlin CV, Hille TD, Ghosh S. Determining the effector response to cell death. Nat Rev Immunol 2021;21:292-304. [PMID: 33188303 DOI: 10.1038/s41577-020-00456-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 Fullerton JN, O'Brien AJ, Gilroy DW. Pathways mediating resolution of inflammation: when enough is too much. J Pathol 2013;231:8-20. [PMID: 23794437 DOI: 10.1002/path.4232] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
50 Pittet JF, Koh H, Fang X, Iles K, Christiaans S, Anjun N, Wagener BM, Park DW, Zmijewski JW, Matthay MA, Roux J. HMGB1 accelerates alveolar epithelial repair via an IL-1β- and αvβ6 integrin-dependent activation of TGF-β1. PLoS One 2013;8:e63907. [PMID: 23696858 DOI: 10.1371/journal.pone.0063907] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
51 Pisetsky DS. The role of HMGB1 in efferocytosis: when the dead go unburied . Focus on “HMGB1 inhibits macrophage activity in efferocytosis through binding to the α v β 3 -integrin”. American Journal of Physiology-Cell Physiology 2010;299:C1253-5. [DOI: 10.1152/ajpcell.00397.2010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
52 Sitapara RA, Antoine DJ, Sharma L, Patel VS, Ashby CR Jr, Gorasiya S, Yang H, Zur M, Mantell LL. The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med 2014;20:238-47. [PMID: 24664237 DOI: 10.2119/molmed.2013.00086] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
53 Wang M, Gauthier A, Daley L, Dial K, Wu J, Woo J, Lin M, Ashby C, Mantell LL. The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases. Antioxid Redox Signal 2019;31:954-93. [PMID: 31184204 DOI: 10.1089/ars.2019.7818] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
54 Höhne C, Wenzel M, Angele B, Hammerschmidt S, Häcker H, Klein M, Bierhaus A, Sperandio M, Pfister H, Koedel U. High mobility group box 1 prolongs inflammation and worsens disease in pneumococcal meningitis. Brain 2013;136:1746-59. [DOI: 10.1093/brain/awt064] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
55 Li K, Chen G, Luo H, Li J, Liu A, Yang C, Wang J, Xu J, Gao S, Chen P, Jiang Y. MRP8/14 mediates macrophage efferocytosis through RAGE and Gas6/MFG-E8, and induces polarization via TLR4-dependent pathway. J Cell Physiol 2021;236:1375-90. [PMID: 33128793 DOI: 10.1002/jcp.29944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Levine JS, Ucker DS. Voices from the dead: The complex vocabulary and intricate grammar of dead cells. Adv Protein Chem Struct Biol 2019;116:1-90. [PMID: 31036289 DOI: 10.1016/bs.apcsb.2019.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Kumar S, Calianese D, Birge RB. Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment. Immunol Rev 2017;280:149-64. [PMID: 29027226 DOI: 10.1111/imr.12587] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
58 Linton MF, Babaev VR, Huang J, Linton EF, Tao H, Yancey PG. Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis. Circ J 2016;80:2259-68. [PMID: 27725526 DOI: 10.1253/circj.CJ-16-0924] [Cited by in Crossref: 76] [Cited by in F6Publishing: 51] [Article Influence: 12.7] [Reference Citation Analysis]
59 Yurdagul A Jr, Doran AC, Cai B, Fredman G, Tabas IA. Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis. Front Cardiovasc Med 2017;4:86. [PMID: 29379788 DOI: 10.3389/fcvm.2017.00086] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 20.8] [Reference Citation Analysis]
60 Bae JS. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Arch Pharm Res 2012;35:1511-23. [PMID: 23054707 DOI: 10.1007/s12272-012-0901-5] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 13.1] [Reference Citation Analysis]
61 Huang LF, Yao YM, Sheng ZY. Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: A systemic review. World J Emerg Med 2012;3:165-71. [PMID: 25215057 DOI: 10.5847/wjem.j.issn.1920-8642.2012.03.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
62 González I, Romero J, Rodríguez BL, Pérez-Castro R, Rojas A. The immunobiology of the receptor of advanced glycation end-products: trends and challenges. Immunobiology 2013;218:790-7. [PMID: 23182709 DOI: 10.1016/j.imbio.2012.09.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
63 Bauer EM, Zheng H, Lotze MT, Bauer PM. Recombinant human interferon alpha 2b prevents and reverses experimental pulmonary hypertension. PLoS One 2014;9:e96720. [PMID: 24837600 DOI: 10.1371/journal.pone.0096720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
64 Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, Wang H, Yang H, Sharma L, Phan BD. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis. Mol Med. 2012;18:477-485. [PMID: 22314397 DOI: 10.2119/molmed.2012.00024] [Cited by in Crossref: 59] [Cited by in F6Publishing: 68] [Article Influence: 5.9] [Reference Citation Analysis]
65 Kim ID, Lee JK. HMGB1-Binding Heptamer Confers Anti-Inflammatory Effects in Primary Microglia Culture. Exp Neurobiol 2013;22:301-7. [PMID: 24465145 DOI: 10.5607/en.2013.22.4.301] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
66 Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal. 2011;14:1315-1335. [PMID: 20969478 DOI: 10.1089/ars.2010.3356] [Cited by in Crossref: 322] [Cited by in F6Publishing: 304] [Article Influence: 29.3] [Reference Citation Analysis]
67 Hossny E, El-Ghoneimy D, Soliman DA, Ashour A. Diagnostic value of serum high-mobility group box-1 in pediatric systemic lupus erythematosus. Int J Rheum Dis 2019;22:1402-9. [PMID: 30938057 DOI: 10.1111/1756-185X.13556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Schaper F, Westra J, Bijl M. Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus. Mol Med 2014;20:72-9. [PMID: 24531837 DOI: 10.2119/molmed.2014.00019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
69 Gaggar A, Rowe SM, Matthew H, Blalock JE. Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation. Open Respir Med J 2010;4:32-8. [PMID: 20448817 DOI: 10.2174/1874306401004020032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
70 Takakubo Y, Konttinen YT. Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases. Clin Dev Immunol 2012;2012:941346. [PMID: 22110541 DOI: 10.1155/2012/941346] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
71 Li L, Lu YQ. The Regulatory Role of High-Mobility Group Protein 1 in Sepsis-Related Immunity. Front Immunol 2020;11:601815. [PMID: 33552058 DOI: 10.3389/fimmu.2020.601815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
72 Entezari M, Javdan M, Antoine DJ, Morrow DM, Sitapara RA, Patel V, Wang M, Sharma L, Gorasiya S, Zur M. Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury. Redox Biol. 2014;2:314-322. [PMID: 24563849 DOI: 10.1016/j.redox.2014.01.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
73 Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: Failure of resolution of inflammation? Pharmacol Ther 2021;218:107670. [PMID: 32891711 DOI: 10.1016/j.pharmthera.2020.107670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
74 Friggeri A, Yang Y, Banerjee S, Park YJ, Liu G, Abraham E. HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. Am J Physiol Cell Physiol 2010;299:C1267-76. [PMID: 20826760 DOI: 10.1152/ajpcell.00152.2010] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 6.7] [Reference Citation Analysis]
75 Davis K, Banerjee S, Friggeri A, Bell C, Abraham E, Zerfaoui M. Poly(ADP-ribosyl)ation of high mobility group box 1 (HMGB1) protein enhances inhibition of efferocytosis. Mol Med 2012;18:359-69. [PMID: 22204001 DOI: 10.2119/molmed.2011.00203] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
76 Bouchery T, Harris N. Neutrophil-macrophage cooperation and its impact on tissue repair. Immunol Cell Biol 2019;97:289-98. [PMID: 30710448 DOI: 10.1111/imcb.12241] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
77 Bergmann C, Strohbuecker L, Lotfi R, Sucker A, Joosten I, Koenen H, Körber A. High mobility group box 1 is increased in the sera of psoriatic patients with disease progression. J Eur Acad Dermatol Venereol 2016;30:435-41. [PMID: 26834049 DOI: 10.1111/jdv.13564] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
78 Banerjee S, de Freitas A, Friggeri A, Zmijewski JW, Liu G, Abraham E. Intracellular HMGB1 negatively regulates efferocytosis. J Immunol 2011;187:4686-94. [PMID: 21957148 DOI: 10.4049/jimmunol.1101500] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
79 Haydar D, Gonzalez R, Garvy BA, Garneau-Tsodikova S, Thamban Chandrika N, Bocklage TJ, Feola DJ. Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia. Immunobiology 2021;226:152034. [PMID: 33278710 DOI: 10.1016/j.imbio.2020.152034] [Reference Citation Analysis]
80 Weigert A, Jennewein C, Brüne B. The liaison between apoptotic cells and macrophages--the end programs the beginning. Biol Chem 2009;390:379-90. [PMID: 19335180 DOI: 10.1515/BC.2009.048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
81 Ross KA. Coherent somatic mutation in autoimmune disease. PLoS One 2014;9:e101093. [PMID: 24988487 DOI: 10.1371/journal.pone.0101093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
82 Antwi-Baffour S, Kholia S, Aryee YK, Ansa-Addo EA, Stratton D, Lange S, Inal JM. Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells--possible role in SLE. Biochem Biophys Res Commun 2010;398:278-83. [PMID: 20599722 DOI: 10.1016/j.bbrc.2010.06.079] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
83 Nichols DP, Chmiel JF. Inflammation and its genesis in cystic fibrosis. Pediatr Pulmonol. 2015;50 Suppl 40:S39-S56. [PMID: 26335954 DOI: 10.1002/ppul.23242] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 17.5] [Reference Citation Analysis]
84 Banerjee S, Friggeri A, Liu G, Abraham E. The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis. J Leukoc Biol 2010;88:973-9. [PMID: 20682624 DOI: 10.1189/jlb.0510262] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
85 Tripathi A, Shrinet K, Kumar A. HMGB1 protein as a novel target for cancer. Toxicol Rep 2019;6:253-61. [PMID: 30911468 DOI: 10.1016/j.toxrep.2019.03.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
86 Jayasundara N, Gardner LD, Block BA. Effects of temperature acclimation on Pacific bluefin tuna ( Thunnus orientalis ) cardiac transcriptome. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2013;305:R1010-20. [DOI: 10.1152/ajpregu.00254.2013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
87 Zhu CJ, Yang WG, Li DJ, Song YD, Chen SY, Wang QF, Liu YN, Zhang Y, Cheng B, Wu ZW, Cui ZC. Calycosin attenuates severe acute pancreatitis-associated acute lung injury by curtailing high mobility group box 1 - induced inflammation. World J Gastroenterol 2021; 27(44): 7669-7686 [PMID: 34908806 DOI: 10.3748/wjg.v27.i44.7669] [Reference Citation Analysis]
88 Houston N, Stewart N, Smith DS, Bell SC, Champion AC, Reid DW. Sputum neutrophils in cystic fibrosis patients display a reduced respiratory burst. J Cyst Fibros 2013;12:352-62. [PMID: 23267772 DOI: 10.1016/j.jcf.2012.11.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
89 Cockram TOJ, Dundee JM, Popescu AS, Brown GC. The Phagocytic Code Regulating Phagocytosis of Mammalian Cells. Front Immunol 2021;12:629979. [PMID: 34177884 DOI: 10.3389/fimmu.2021.629979] [Reference Citation Analysis]
90 Thorp EB. Contrasting Inflammation Resolution during Atherosclerosis and Post Myocardial Infarction at the Level of Monocyte/Macrophage Phagocytic Clearance. Front Immunol. 2012;3:39. [PMID: 22566922 DOI: 10.3389/fimmu.2012.00039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
91 Vogel S, Börger V, Peters C, Förster M, Liebfried P, Metzger K, Meisel R, Däubener W, Trapp T, Fischer JC, Gawaz M, Sorg RV. Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. Cell Death Differ 2015;22:1219-30. [PMID: 25571972 DOI: 10.1038/cdd.2014.225] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
92 Wang H, Ward MF, Sama AE. Targeting HMGB1 in the treatment of sepsis. Expert Opin Ther Targets 2014;18:257-68. [PMID: 24392842 DOI: 10.1517/14728222.2014.863876] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 9.8] [Reference Citation Analysis]
93 Zheng S, Kummarapurugu AB, Afosah DK, Sankaranarayanan NV, Boothello RS, Desai UR, Kennedy T, Voynow JA. 2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity. Am J Respir Cell Mol Biol 2017;56:90-8. [PMID: 27585400 DOI: 10.1165/rcmb.2016-0069OC] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
94 García-Arnandis I, Guillén MI, Castejón MA, Gomar F, Alcaraz MJ. Haem oxygenase-1 down-regulates high mobility group box 1 and matrix metalloproteinases in osteoarthritic synoviocytes. Rheumatology (Oxford) 2010;49:854-61. [PMID: 20110250 DOI: 10.1093/rheumatology/kep463] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
95 Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M. HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development. Autoimmun Rev. 2010;9:661-665. [PMID: 20546955 DOI: 10.1016/j.autrev.2010.05.015] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
96 Miao J, Ye P, Lan J, Ye S, Zhong J, Gresham A, Li S, You A, Chen X, Liu X, Li H. Paeonol promotes the phagocytic ability of macrophages through confining HMGB1 to the nucleus. Int Immunopharmacol 2020;89:107068. [PMID: 33091813 DOI: 10.1016/j.intimp.2020.107068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Wood B, Padula MP, Marks DC, Johnson L. Cryopreservation alters the immune characteristics of platelets. Transfusion 2021. [PMID: 34636427 DOI: 10.1111/trf.16697] [Reference Citation Analysis]
98 Ley S, Weigert A, Brüne B. Neuromediators in inflammation—a macrophage/nerve connection. Immunobiology 2010;215:674-84. [DOI: 10.1016/j.imbio.2010.05.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
99 Kang GJ, Lee HJ, Byun HJ, Kim EJ, Kim HJ, Park MK, Lee CH. Novel involvement of miR-522-3p in high-mobility group box 1-induced prostaglandin reductase 1 expression and reduction of phagocytosis. Biochim Biophys Acta Mol Cell Res 2017;1864:625-33. [PMID: 28088550 DOI: 10.1016/j.bbamcr.2017.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
100 Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta. 2010;1799:131-140. [PMID: 20123075 DOI: 10.1016/j.bbagrm.2009.11.014] [Cited by in Crossref: 334] [Cited by in F6Publishing: 345] [Article Influence: 27.8] [Reference Citation Analysis]
101 Liou TG, Adler FR, Keogh RH, Li Y, Jensen JL, Walsh W, Packer K, Clark T, Carveth H, Chen J, Rogers SL, Lane C, Moore J, Sturrock A, Paine R 3rd, Cox DR, Hoidal JR. Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. PLoS One 2012;7:e42748. [PMID: 22916155 DOI: 10.1371/journal.pone.0042748] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
102 Jung J, Suh C, Sohn S, Nam J, Kim H. Elevated high-mobility group B1 levels in active adult-onset Still’s disease associated with systemic score and skin rash. Clin Rheumatol 2016;35:1937-42. [DOI: 10.1007/s10067-016-3314-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
103 Park YJ, Liu G, Tsuruta Y, Lorne E, Abraham E. Participation of the urokinase receptor in neutrophil efferocytosis. Blood 2009;114:860-70. [PMID: 19398720 DOI: 10.1182/blood-2008-12-193524] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
104 Kaur I, Behl T, Bungau S, Kumar A, Mehta V, Setia D, Uddin MS, Zengin G, Aleya L, Arora S. Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis. Life Sci 2020;258:118164. [PMID: 32739467 DOI: 10.1016/j.lfs.2020.118164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
105 Grabiec AM, Hussell T. The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation. Semin Immunopathol 2016;38:409-23. [PMID: 26957481 DOI: 10.1007/s00281-016-0555-3] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 13.8] [Reference Citation Analysis]
106 Tadié JM, Bae HB, Banerjee S, Zmijewski JW, Abraham E. Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing. Am J Physiol Cell Physiol 2012;302:C249-56. [PMID: 22012330 DOI: 10.1152/ajpcell.00302.2011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
107 Ma CY, Jiao YL, Zhang J, Yang QR, Zhang ZF, Shen YJ, Chen ZJ, Zhao YR. Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus. Rheumatol Int 2012;32:395-402. [PMID: 21120500 DOI: 10.1007/s00296-010-1636-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
108 Yurdagul A, Doran AC, Cai B, Fredman G, Tabas IA. Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis. Front Cardiovasc Med. 2018;4:86. [PMID: 29379788 DOI: 10.3389/fcvm.2017.00086e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Stämpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 2009;9:377-84. [PMID: 19330016 DOI: 10.1038/nri2530] [Cited by in Crossref: 387] [Cited by in F6Publishing: 368] [Article Influence: 29.8] [Reference Citation Analysis]
110 Krysko O, Vandenabeele P, Krysko DV, Bachert C. Impairment of phagocytosis of apoptotic cells and its role in chronic airway diseases. Apoptosis 2010;15:1137-46. [PMID: 20449769 DOI: 10.1007/s10495-010-0504-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
111 Friggeri A, Banerjee S, Xie N, Cui H, De Freitas A, Zerfaoui M, Dupont H, Abraham E, Liu G. Extracellular histones inhibit efferocytosis. Mol Med 2012;18:825-33. [PMID: 22495510 DOI: 10.2119/molmed.2012.00005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
112 Kim I, Shin J, Lee H, Jin Y, Lee J. Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain. Neuroscience Letters 2012;525:179-83. [DOI: 10.1016/j.neulet.2012.07.040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
113 Davies SP, Reynolds GM, Stamataki Z. Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis. Front Immunol 2018;9:44. [PMID: 29422896 DOI: 10.3389/fimmu.2018.00044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
114 Tang H, Zhao H, Song J, Dong H, Yao L, Liang Z, LV Y, Zou F, Cai S. Ethyl pyruvate decreases airway neutrophil infiltration partly through a high mobility group box 1-dependent mechanism in a chemical-induced murine asthma model. Int Immunopharmacol 2014;21:163-70. [PMID: 24819717 DOI: 10.1016/j.intimp.2014.04.024] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
115 Yang Y, Friggeri A, Banerjee S, Bdeir K, Cines DB, Liu G, Abraham E. Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils. Am J Respir Crit Care Med 2010;182:1516-23. [PMID: 20656938 DOI: 10.1164/rccm.201003-0452OC] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
116 Penn DL, Kim C, Zhang K, Mukherjee A, Devakumar D, Jungkind D, Thakur ML. Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V. Nucl Med Biol 2010;37:29-34. [PMID: 20122665 DOI: 10.1016/j.nucmedbio.2009.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
117 Urbonaviciute V, Voll RE. High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus: Symposium: HMGB1 in the pathogenesis of SLE. Journal of Internal Medicine 2011;270:309-18. [DOI: 10.1111/j.1365-2796.2011.02432.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
118 Wang H, Ward MF, Sama AE. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock. 2009;32:348-357. [PMID: 19333143 DOI: 10.1097/SHK.0b013e3181a551bd] [Cited by in Crossref: 87] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
119 Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho AF, Maes M, Walder K, Berk M. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach. Life Sci. 2020;258:118166. [PMID: 32739471 DOI: 10.1016/j.lfs.2020.118166] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
120 Corneth OBJ, Schaper F, Luk F, Asmawidjaja PS, Mus AMC, Horst G, Heeringa P, Hendriks RW, Westra J, Lubberts E. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice. Sci Rep 2019;9:4032. [PMID: 30858513 DOI: 10.1038/s41598-019-39483-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
121 Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D. HMGB1 in health and disease. Mol Aspects Med 2014;40:1-116. [PMID: 25010388 DOI: 10.1016/j.mam.2014.05.001] [Cited by in Crossref: 445] [Cited by in F6Publishing: 443] [Article Influence: 55.6] [Reference Citation Analysis]
122 Sorci G, Riuzzi F, Giambanco I, Donato R. RAGE in tissue homeostasis, repair and regeneration. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013;1833:101-9. [DOI: 10.1016/j.bbamcr.2012.10.021] [Cited by in Crossref: 126] [Cited by in F6Publishing: 126] [Article Influence: 14.0] [Reference Citation Analysis]
123 Rieger D, Assinger A, Einfinger K, Sokolikova B, Geiger M. Protein C inhibitor (PCI) binds to phosphatidylserine exposing cells with implications in the phagocytosis of apoptotic cells and activated platelets. PLoS One 2014;9:e101794. [PMID: 25000564 DOI: 10.1371/journal.pone.0101794] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
124 Chen Y, Li G, Liu Y, Werth VP, Williams KJ, Liu ML. Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages. J Cell Physiol 2016;231:2319-26. [PMID: 26909509 DOI: 10.1002/jcp.25352] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]